Biopharmaceuticals - 191 News

Boehringer Ingelheim inaugurates largest European development centre for biotechnology

Investment of 350 million euros is Boehringer Ingelheim's largest single investment in Germany to date

26-Apr-2023 - Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center (BDC) in Biberach an der Riß, Germany. The new high-tech facility underlines the company’s strong commitment to Germany and Europe as location for research and development (R&D) for the care of patients around ...

Medicines with Sugar Chains

Native top-down mass spectrometry reveals role of glycans in protein oligomers

17-Nov-2022 - Many proteins contain patterns of sugar molecules (glycans) and are made of several aggregated subunits. This glycosylation and oligomerization has a decisive influence on protein function and must be considered in biopharmaceutical development. In the journal Angewandte Chemie, a British team ...

eversyn awarded with EXIST Research Transfer Grant for the Production of Glycans for Food and Pharma Industry

Spin-off Project of the Max Planck Institute Magdeburg

27-Oct-2022 - eversyn is a start-up of the Department of Bioprocessing Engineering at the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg. The project has been awarded an EXIST Research Transfer grant of over € 900,000 to support its spin-off activities. eversyn will use its ...

Sartorius closes fiscal 2021 with 50 percent growth and a jump in profitability

Number of employees rises by 30 percent to nearly 14,000

27-Jan-2022 - Due to the excellent development of its core business, additional demand generated by the coronavirus pandemic, and several acquisitions, the life science group Sartorius closed fiscal 2021 with exceptionally strong growth and a jump in profitability. According to preliminary figures, the company ...

Rentschler Biopharma breaks ground at new U.S. production site in greater Boston

Multi-product facility to focus on commercial production of complex molecules for U.S.-based clients

16-Aug-2021 - Rentschler Biopharma announced that the company has broken ground at its new production site, adjacent to its existing site in Milford, MA in the greater Boston area. The new Rentschler Biopharma Manufacturing Center US (RBMC US) will add 22,000 square feet of manufacturing cleanroom space and ...

WACKER Strengthens Biologics Business by Acquiring US-Based Plasmid DNA Manufacturer Genopis

Expansion of WACKER's portfolio as a contract manufacturer for the pharmaceutical industry

04-Feb-2021 - The Munich-based chemical company WACKER is acquiring 100 percent of the shares in pharmaceutical contract manufacturer Genopis Inc. from Helixmith Co Ltd, Seoul (South Korea) and Medivate Partners LLC, Seoul (South Korea). WACKER signed a corresponding agreement. WACKER will continue Genopis' ...

Merck Invests in State-Of-The-Art Biotech Development Facility in Switzerland

28-Jan-2020 - Merck announced an investment of €250million in a new facility in Corsier-sur-Vevey, Switzerland – the Merck Biotech Development Center – dedicated to biotech development and manufacturing for clinical studies. Driven by the growth of the Healthcare business sector R&D pipeline, this investment ...

Turbo-charging pharmaceutical biotechnology simulations

New simulation technology is designed to make the production of biopharmaceuticals more efficient, cost-effective and comprehensible

13-Sep-2019 - Demand for biopharmaceuticals is strong: biopharmaceutical active ingredients – in other words, genetically engineered drugs – accounted for seven of the ten top-selling medications in the world in 2018. And the proportion is set to rise, as biopharmaceuticals can be used to combat conditions ...

Protagen Protein Services and BioAnalytix Merge

Create Global Analytic Service Partner for Biopharmaceuticals

15-Apr-2019 - Protagen Protein Services GmbH (PPS), a full-service contract research organization (CRO) in protein analytics and BioAnalytix Inc., a Cambridge(MA)-based specialized provider of advanced analytics in biologic development announced a merger that will transform the combined company into a leading ...

Lonza to Establish Strategic Biomanufacturing Base in China

13-Dec-2018 - Lonza announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN). As the facility is part of a larger biomanufacturing initiative between GE Healthcare and Guangzhou Development District (GDD), the agreement will be finalized ...